LFSC Holdings Information

LFSC is an equity ETF with a total of 44 individual holdings. The top holdings are Cogent Biosciences stock at 8.21%, Travere Therapeutics at 7.00%, LivaNova at 6.62%, Spyre Therapeutics at 6.37%, and Mirum Pharmaceuticals at 4.70%.

Total Holdings

Top 10 Percentage

54.64%

Asset Class

Equity

ETF Category

Health

Assets

99.94M

PE Ratio

n/a

Breakdown by Sector

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	COGT	Cogent Biosciences, Inc.	8.21%	226,142
2	TVTX	Travere Therapeutics, Inc.	7.00%	170,714
3	LIVN	LivaNova PLC	6.62%	101,212
4	SYRE	Spyre Therapeutics, Inc.	6.37%	91,588
5	MIRM	Mirum Pharmaceuticals, Inc.	4.70%	50,911
6	NKTR	Nektar Therapeutics	4.66%	50,876
7	UTHR	United Therapeutics Corporation	4.51%	7,841
8	KALV	KalVista Pharmaceuticals, Inc.	4.35%	226,991
9	n/a	US DOLLARS	4.21%	4,186,380
10	TMDX	TransMedics Group, Inc.	4.00%	35,164
11	GH	Guardant Health, Inc.	3.95%	44,694
12	BBIO	BridgeBio Pharma, Inc.	3.70%	51,359
13	TRVI	Trevi Therapeutics, Inc.	3.30%	231,602
14	SVRA	Savara Inc.	3.23%	651,024
15	AXSM	Axsome Therapeutics, Inc.	2.34%	12,723
16	ICUI	ICU Medical, Inc.	2.03%	16,227
17	CYTK	Cytokinetics, Incorporated	1.95%	29,588
18	MANE	Veradermics, Incorporated	1.92%	27,629
19	CBLL	CeriBell, Inc.	1.87%	88,354
20	PVLA	Palvella Therapeutics, Inc.	1.77%	13,839
21	CRVS	Corvus Pharmaceuticals, Inc.	1.61%	100,029
22	GMED	Globus Medical, Inc.	1.54%	16,258
23	CORT	Corcept Therapeutics Incorporated	1.53%	33,771
24	DNTH	Dianthus Therapeutics, Inc.	1.52%	16,865
25	VRDN	Viridian Therapeutics, Inc.	1.52%	106,184

Showing 25 of 44 holdings

Subscribe to see the full list

Activate Now

As of Apr 23, 2026